CEL-SCI CEO-linked trust buys 300K shares
CEL SCI CORP director and CEO Geert Kersten reported a significant insider purchase through a related trust.
Rhea-AI Filing Summary
CEL SCI CORP director and CEO Geert Kersten reported a significant insider purchase through a related trust. On May 14, 2026, the de Clara Trust, for which Mr. Kersten serves as trustee, bought 300,000 shares of restricted common stock directly from the company at $1.20 per share, equal to the most recent closing price on May 13, 2026.
After this transaction, Mr. Kersten is shown with 210,950 common shares held directly and 311,547 common shares held indirectly as trustee of the de Clara Trust. The filing shows no derivative securities remaining after this activity.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 300,000 shares
Net Buy
2 txns
Insider
KERSTEN GEERT R
Role
Chief Executive Officer
Bought
300,000 shs ($360K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 300,000 | $1.20 | $360K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 311,547 shares (Indirect, Trustee);
Common Stock — 210,950 shares (Direct)
Footnotes (1)
- F1. On May 14, 2026, the de Clara Trust, of which Mr. Kersten is a trustee, purchased 300,000 shares of restricted stock directly from the Company at the closing price on May 13, 2026, the most recent closing price available.
Key Figures
Restricted shares purchased: 300,000 shares
Purchase price: $1.20 per share
Direct common shares after: 210,950 shares
+2 more
5 metrics
Restricted shares purchased
300,000 shares
Bought by de Clara Trust on May 14, 2026
Purchase price
$1.20 per share
Equal to May 13, 2026 closing price
Direct common shares after
210,950 shares
Direct holdings following reported transactions
Indirect common shares after
311,547 shares
Held indirectly as trustee of de Clara Trust
Net share direction
300,000 net-buy shares
Form 4 transaction summary for common stock
Key Terms
restricted stock, trustee, indirect, open-market purchase, +1 more
5 terms
restricted stock financial
"purchased 300,000 shares of restricted stock directly from the Company"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
trustee financial
"the de Clara Trust, of which Mr. Kersten is a trustee, purchased"
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
indirect financial
"311,547 common shares held indirectly as trustee of the de Clara Trust"
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Form 4 financial
"according to the ownership details disclosed in the Form 4 filing"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CEL SCI CORP (CVM) report for Geert Kersten?
CEL SCI CORP reported that the de Clara Trust, with CEO Geert Kersten as trustee, purchased 300,000 restricted common shares. The shares were bought directly from the company, reflecting an increase in insider-associated ownership through a related trust structure.
Was the CEL SCI CORP insider transaction an open-market purchase?
The coded transaction is categorized as an open-market or private purchase, but the footnote clarifies that the de Clara Trust bought 300,000 restricted shares directly from CEL SCI CORP at the most recent closing price, rather than through a public market trade.
Did the CEL SCI CORP Form 4 show any option exercises or derivative trades?
The Form 4 does not list any option exercises or derivative security trades. The derivative transactions count is zero, and the filing focuses on common stock positions held directly and indirectly following the trust’s restricted stock purchase.
AI-generated analysis. How Rhea-AI works. Not financial advice.
